On Tuesday, Yahoo! Inc.(NASDAQ:YHOO)’s shares declined -2.47% to $30.40.
FBR has updated its view on Yahoo! Inc. (NASDAQ:YHOO). The firm has maintained Outperform rating on Yahoo but cut its 12-month price target on the stock to $39 from $50. Of key interest is that FBR said its latest comment on Yahoo assumes that the company will succeed in the push to spin off the stake in Alibaba Group Holdings Ltd (NYSE:BABA) in a tax-efficient manner. On the issue of tax-free spinoff of the stake in Alibaba, FBR said that IRS was unlikely to apply what might be interpreted as retrogressive rules, thus allowing Yahoo to do the transaction in the manner it as applied to do it.
The other thing that makes FBR excited about Yahoo! Inc. (NASDAQ:YHOO) is that it sees the company growing its core business. Yahoo has been actively investing in mobile, social and video, which have the potential of offsetting the declines in its legacy PC display ad business.
Yahoo! Inc. provides search and display advertising services on Yahoo properties and associate sites worldwide. The company offers Yahoo Search that serves as a starting point to navigate the Internet and discover information; and Yahoo Answers, which enables users to seek, discover, and share knowledge and opinions across mobile phones, tablets, and desktops.
Kinder Morgan Inc(NYSE:KMI)’s shares dropped -1.86% to $30.10.
Kinder Morgan, Inc. (KMI) declared it will extend its current binding open season to review shipper comments and interest received to date, in addition to continue to seek commitments for the projected Utica Marcellus Texas Pipeline (UMTP) project, which would transport natural gas liquids and condensate produced from the Utica and Marcellus basins to delivery points along the Texas Gulf Coast, counting connectivity to a Kinder Morgan dock located along the Houston Ship Channel. The binding open season planned to end recently will now end at 5 p.m. Central Time on Dec. 15, 2015.
The projected project would involve the abandonment and conversion of 964 miles of natural gas service on KMI’s existing Tennessee Gas Pipeline, the construction of about 200 miles of new pipeline from Louisiana to Texas, new storage in Ohio and 120 miles of new laterals to provide basin connectivity.
Kinder Morgan, Inc. operates as an energy infrastructure and energy company in North America. The company operates through Natural Gas Pipelines, CO2, Terminals, Products Pipelines, Kinder Morgan Canada, and Other segments.
At the end of Tuesday’s trade, Abbott Laboratories (NYSE:ABT)‘s shares dipped -1.92% to $42.47.
Abbott (ABT) declared it received Health Canada’s approval of the TECNIS® Symfony Extended Range of Vision intraocular lens (IOL) for the treatment of people with cataracts who may also have a diminished ability to focus on near objects (presbyopia). It is the first and only extended range of vision IOL to correct presbyopia and assist people with cataracts see better at all distances, counting far, intermediate and near, and points in between, with reduced need for glasses.1,2
A cataract is a gradual clouding of the natural lens of the eye that prevents light from reaching the retina.3 More than 2.5 million Canadians have cataracts. The incidence of cataracts enhances with age from about 12 per cent at age 50, to 60 per cent at age 70.5 In general, about 50 per cent of Canadians 65 years of age or older have cataracts.
Traditionally after cataract surgery, people may still require eyeglasses.7, 8 However, a clinical study of 31 people who had the TECNIS Symfony IOL implanted showed 70 per cent of them reporting rarely or never requiring wearing glasses. One hundred per cent of people who had the lens implanted stated they did not need to wear glasses for seeing objects at distance, while 94 per cent and 87 per cent of people stated the same results at intermediate and near distances, respectively.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
United Continental Holdings Inc(NYSE:UAL), ended its Tuesday’s trading session with -3.64% loss, and closed at $58.25.
Chase Card Services, a division of JPMorgan Chase & Co. [JPM], Visa Inc. [V] and United Airlines [UAL] declared the extension of the popular United MileagePlus® credit card program. The multi-year agreements extend the more than 20-year legacy of providing exceptional benefits tailored for consumer and business cardmembers.
This extension will continue offering a rich credit card program across multiple products counting the United MileagePlus® Explorer, United MileagePlus® Explorer Business and United MileagePlus® Club cards.
Additionally, cardmembers will continue to enjoy access to exclusive events with InsideAccess.com in addition to exclusive luxury hotel and resort privileges.
United Continental Holdings, Inc., together with its auxiliaries, provides air transportation services in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. It transports people and cargo through its mainline operations, which use jet aircraft with at least 118 seats, and its regional operations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
